Market research
000250.KO Sam Chun Dang Pharm Co. Ltd.
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 000250.KO discussion.
5 years, 6 months ago
Sam Chun Dang Pharm Co. Ltd. is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Sam Chun Dang Pharm Co. Ltd.'s total revenue sank by 11.5% to $39B since the same quarter in the previous year.
Its net income has increased by 294.6% to $5B since the same quarter in the previous year.
Finally, its free cash flow fell by 84.2% to $57M since the same quarter in the previous year.
Based on the above factors, Sam Chun Dang Pharm Co. Ltd. gets an overall score of 2/5.